PedAM
Pediatric Disease Annotations & Medicines
| Disease | cardiomyopathy |
| Symptom | C0028754|obesity |
| Sentences | 9 |
| PubMedID- 23817015 | Background: although obesity increases the risk of developing cardiomyopathy, the mechanisms underlying the development of this cardiomyopathy are incompletely understood. |
| PubMedID- 24342999 | For decades, it has been known that obesity is closely associated with cardiomyopathy and hypertrophy.17–19 in recent years, chronic inflammation emerged as a potential leading cause of obesity‐associated heart diseases,7–11 but the mechanisms remain to be elucidated. |
| PubMedID- 23978095 | The role of obesity in cardiomyopathy and nephropathy. |
| PubMedID- 25018087 | obesity-induced cardiomyopathy may be mediated by alterations in multiple signaling cascades involved in glucose and lipid metabolism. |
| PubMedID- 23508767 | Diabetes and obesity are both associated with lipotoxic cardiomyopathy exclusive of coronary artery disease and hypertension. |
| PubMedID- 23302153 | cardiomyopathy in obesity is associated with left ventricular hypertrophy and diastolic dysfunction with a longer exposure to obesity associated with worse cardiac function and larger ventricular mass . |
| PubMedID- 24614171 | Many studies have shown that mitochondrial biogenesis and function are impaired in lipotoxic cardiomyopathy associated with obesity and diabetes , and that mitochondrial dysfunction is linked to cardiac dysfunction . |
| PubMedID- 22465089 | The cardiomyopathy seen with obesity is associated with increased interstitial fibrosis and diastolic dysfunction. |
| PubMedID- 23196711 | obesity-related diabetes mellitus leads to lipotoxic cardiomyopathy resulting in a form of cardiac dysfunction. |
Page: 1